Dedifferentiated liposarcoma and pleomorphic liposarcoma

Cancer Cytopathology

Volumn 122, Issue 2, 2014, Pages 128-137

  Marĩno Enríquez, Adrían ^a   Hornick, Jason L ^a   Dal Cin, Paola ^a   Cibas, Edmund S ^a   Qian, Xiaohua ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adipocytic; CDK4; Cytology; Dedifferentiated liposarcoma; Fine needle aspirate; Lipoblast; MDM2; Pleomorphic liposarcoma; Sarcoma; Soft tissue

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2; CDK4 PROTEIN, HUMAN;

ADULT; AGED; CELL DEATH; CELL NUCLEUS; CELL STRUCTURE; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOPLASM; DEDIFFERENTIATED LIPOSARCOMA; EPITHELIOID CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KARYOTYPE; LIPOSARCOMA; MALE; MIDDLE AGED; MITOSIS; PLEOMORPHIC LIPOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SPINDLE CELL; VERY ELDERLY; YOUNG ADULT; ADIPOCYTIC; ARTICLE; CDK4; CHEMISTRY; CHROMOSOME ABERRATION; COMPARATIVE STUDY; CYTOLOGY; FINE NEEDLE ASPIRATION BIOPSY; FINE-NEEDLE ASPIRATE; GENETICS; LIPOBLAST; MDM2; METHODOLOGY; PATHOLOGY; SARCOMA; SOFT TISSUE;

ADIPOCYTIC; CDK4; CYTOLOGY; DEDIFFERENTIATED LIPOSARCOMA; FINE-NEEDLE ASPIRATE; LIPOBLAST; MDM2; PLEOMORPHIC LIPOSARCOMA; SARCOMA; SOFT TISSUE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE 4; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES;

EID: 84897957391     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21362     Document Type: Conference Paper

References (38)

1. Fletcher CDM. Diagnostic Histopathology of Tumors. 4th ed. Philadelphia, PA: Saunders, Elsevier; 2013.
2. McCormick D, Mentzel T, Beham A, Fletcher CD. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213-1223.
3. Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271-281.
4. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. Lyon, France: IARC; 2013.
5. Marino-Enriquez A, Fletcher CD, Dal Cin P, Hornick JL. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol. 2010;34:1122-1131.
6. Boland JM, Weiss SW, Oliveira AM, Erickson-Johnson ML, Folpe AL. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2010;34:837-843.
7. Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CD. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257-1267.
8. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26:601-616.
9. Downes KA, Goldblum JR, Montgomery EA, Fisher C. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001;14:179-184.
10. Coindre JM, Pedeutour F, Aurias A. Well-differentiated and dedifferentiated liposarcomas. Virchows Arch. 2010;456:167-179.
11. Mertens F, Fletcher CD, Dal Cin P, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP study group. CHromosomes And MorPhology. Genes Chromosomes Cancer. 1998;22:16-25.
12. Dal Cin P, Qian X, Cibas ES. The marriage of cytology and cytogenetics. Cancer Cytopathol. 2013;121:279-290.
13. Aleixo PB, Hartmann AA, Menezes IC, Meurer RT, Oliveira AM. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours. J Clin Pathol. 2009;62:1127-1135.
14. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing welldifferentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347.
15. Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol. 2000;190:531-536.
16. Italiano A, Bianchini L, Keslair F, et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008;122:2233-2241.
17. Italiano A, Bianchini L, Gjernes E, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res. 2009;15:5696-5703.
18. Nilbert M, Rydholm A, Mitelman F, Meltzer PS, Mandahl N. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet. 1995;83:32-36.
19. Persson F, Olofsson A, Sjögren H, et al. Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line. Cancer Lett. 2008;260:37-47.
20. Suster S, Morrison C. Sclerosing poorly differentiated liposarcoma: clinicopathological, immunohistochemical and molecular analysis of a distinct morphological subtype of lipomatous tumour of soft tissue. Histopathology. 2008;52:283-293.
21. Weaver J, Rao P, Goldblum JR, et al. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose welldifferentiated liposarcoma? Mod Pathol. 2010;23:1301-1306.
22. Rieker RJ, Joos S, Bartsch C, et al. Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int J Cancer. 2002;99:68-73.
23. Fritz B, Schubert F, Wrobel G, et al. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res. 2002;62:2993-2998.
24. Klijanienko J, Caillaud JM, Lagace R. Fine-needle aspiration in liposarcoma: cytohistologic correlative study including welldifferentiated, myxoid, and pleomorphic variants. Diagn Cytopathol. 2004;30:307-312.
25. Walaas L, Kindblom LG. Lipomatous tumors: a correlative cytologic and histologic study of 27 tumors examined by fine needle aspiration cytology. Hum Pathol. 1985;16:6-18.
26. Akerman M, Rydholm A. Aspiration cytology of lipomatous tumors: a 10-year experience at an orthopedic oncology center. Diagn Cytopathol. 1987;3:295-302.
27. Al-Maghraby HQ, Khalbuss WE, Rao UN, Cieply K, Dacic S, Monaco SE. Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: cytomorphology and MDM2 amplification by FISH. Cytojournal. 2010;7:5.
28. Liegl B, Kepten I, Le C, et al. Heterogeneity of kinase inhibitor resistance mechanisms in GIST. J Pathol. 2008;216:64-74.
29. Nemanqani D, Mourad WA. Cytomorphologic features of fineneedle aspiration of liposarcoma. Diagn Cytopathol. 1999;20:67-69.
30. Kapila K, Ghosal N, Gill SS, Verma K. Cytomorphology of lipomatous tumors of soft tissue. Acta Cytol. 2003;47:555-562.
31. González-Cámpora R, Muñoz-Arias G, Otal-Salaverri C, et al. Fine needle aspiration cytology of primary soft tissue tumors. Morphologic analysis of the most frequent types. Acta Cytol. 1992;36: 905-917.
32. Nagira K, Yamamoto T, Akisue T, et al. Reliability of fine-needle aspiration biopsy in the initial diagnosis of soft-tissue lesions. Diagn Cytopathol 2002;27:354-361.
33. Einarsdóttir H, Skoog L, Söderlund V, Bauer HC. Accuracy of cytology for diagnosis of lipomatous tumors: comparison with magnetic resonance and computed tomography findings in 175 cases. Acta Radiol. 2004;45:840-846.
34. Nikolaidis P, Silverman SG, Cibas ES, et al. Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsy. Eur Radiol. 2005;15:383-389.
35. Vicandi B, Jiménez-Heffernan J, López-Ferrer P, González-Peramato P, Viguer JM. Cytologic features of round cell liposarcoma: a report on five patients. Cancer. 2003;99:28-32.
36. Dodd LG. Update on liposarcoma: a review for cytopathologists. Diagn Cytopathol. 2012;40:1122-1131.
37. Müller CR, Paulsen EB, Noordhuis P, Pedeutour F, Saeter G, Myklebost O. Potential for treatment of liposarcomas with the MDM2 antagonist nutlin-3A. Int J Cancer. 2007;121:199-205.
38. Sioletic S, Dal Cin P, Fletcher CD, Hornick JL. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Histopathology 2013;62:287-293.